{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:54:21Z","timestamp":1758448461801,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jns.2019.116614","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T12:25:13Z","timestamp":1575548713000},"page":"116614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Low heteroplasmy rates in clinically affected m.3243A\u00a0>\u00a0G carriers not necessarily explain the phenotype"],"prefix":"10.1016","volume":"409","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-7305","authenticated-orcid":false,"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.116614_bb0005","doi-asserted-by":"crossref","first-page":"116562","DOI":"10.1016\/j.jns.2019.116562","article-title":"Heteroplasmy and phenotype spectrum of the mitochondrial tRNA(Leu (UUR)) gene m.3243A>G mutation in seven Han Chinese families","volume":"408","author":"Liu","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116614_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mus.25125","article-title":"Novel genetic and neuropathological insights in neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP)","volume":"54","author":"Claeys","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2019.116614_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000357518","article-title":"NARP syndrome: A 20-year follow-up","volume":"5","author":"Rawle","year":"2013","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.jns.2019.116614_bb0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40291-017-0279-7","article-title":"Genetic counselling for maternally inherited mitochondrial disorders","volume":"21","author":"Poulton","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jns.2019.116614_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2019.03.021","article-title":"Mitochondrial metabolic stroke: Phenotype and genetics of stroke-like episodes","volume":"400","author":"Finsterer","year":"2019","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19323792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19323792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:49:39Z","timestamp":1758383379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19323792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":5,"alternative-id":["S0022510X19323792"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.116614","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low heteroplasmy rates in clinically affected m.3243A\u00a0>\u00a0G carriers not necessarily explain the phenotype","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.116614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116614"}}